Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Trevi Therapeutics, Inc. TRVI

Full chart Compare
Set alert

Price alert · TRVI

All alert types
13.99 USD +0.13 (+0.90%)

At closeNov 4, 2026, 5:30 PM EST

13.99 0.00 0.00%

After hours · Nov 4, 5:30 PM ET

13.48 Day range 14.52
9.82 52-week range 20.22
YTD
+11.70%
1 year
+28.78%

Financial health

Altman Z-Score

130.58 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 5
  • P/E 1
  • P/B 1

Valuation

P/E -43.2×
FY 2016: -11.4×FY 2017: -5.5×FY 2018: -3.4×FY 2019: -2.6×FY 2020: -1.3×FY 2021: -0.5×FY 2022: -4.3×FY 2023: -4.6×FY 2024: -8.8×FY 2025: -43.2×
FY 2016 5y median -4.6× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 9.9×
FY 2016: -7.3×FY 2017: 4.8×FY 2018: 4.1×FY 2019: 1.2×FY 2020: 1.6×FY 2021: 1.0×FY 2022: 1.2×FY 2023: 1.6×FY 2024: 4.2×FY 2025: 9.9×
FY 2016 5y median 1.6× FY 2025
P/FCF -43.2×
FY 2016: -11.4×FY 2017: -8.9×FY 2018: -3.8×FY 2019: -2.9×FY 2020: -1.5×FY 2021: -0.6×FY 2022: -4.4×FY 2023: -4.2×FY 2024: -10.9×FY 2025: -43.2×
FY 2016 5y median -4.4× FY 2025
EV/EBITDA -42.1×
FY 2016: -16.4×FY 2017: -6.6×FY 2018: -3.0×FY 2019: -0.4×FY 2020: -0.4×FY 2021: 0.1×FY 2022: -4.3×FY 2023: -3.6×FY 2024: -8.0×FY 2025: -42.1×
FY 2016 5y median -4.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -2.3%
FY 2016: -8.8%FY 2017: -11.3%FY 2018: -26.1%FY 2019: -34.5%FY 2020: -66.4%FY 2021: -162.0%FY 2022: -22.7%FY 2023: -24.0%FY 2024: -9.2%FY 2025: -2.3%
FY 2016 5y median -22.7% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -23.3%
FY 2016: 63.7%FY 2017: -87.0%FY 2018: -118.7%FY 2019: -47.8%FY 2020: -120.1%FY 2021: -198.8%FY 2022: -27.1%FY 2023: -35.2%FY 2024: -48.1%FY 2025: -23.3%
FY 2016 5y median -35.2% FY 2025
ROIC -26.8%
FY 2016: -172.0%FY 2017: -40.3%FY 2018: -102.7%FY 2019: -48.5%FY 2020: -77.9%FY 2021: -102.4%FY 2022: -25.6%FY 2023: -40.4%FY 2024: -51.1%FY 2025: -26.8%
FY 2016 5y median -40.4% FY 2025
ROA -22.1%
FY 2016: -131.8%FY 2017: -57.9%FY 2018: -100.3%FY 2019: -43.4%FY 2020: -69.5%FY 2021: -88.2%FY 2022: -23.7%FY 2023: -32.5%FY 2024: -43.2%FY 2025: -22.1%
FY 2016 5y median -32.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 4.3%
FY 2016: 0.0%FY 2017: 4.5%FY 2018: -123.5%FY 2019: -44.7%FY 2020: -21.9%FY 2021: 0.0%FY 2022: 7.9%FY 2023: -13.4%FY 2024: -51.9%FY 2025: 4.3%
FY 2016 FY 2025
EPS (diluted) 38.3%
FY 2016: 0.0%FY 2017: -107.2%FY 2018: -60.1%FY 2019: 36.2%FY 2020: -24.0%FY 2021: 17.7%FY 2022: 69.8%FY 2023: 35.6%FY 2024: -62.1%FY 2025: 38.3%
FY 2016 FY 2025
Free Cash Flow -10.0%
FY 2016: 0.0%FY 2017: 28.6%FY 2018: -131.0%FY 2019: -25.2%FY 2020: -25.7%FY 2021: 0.3%FY 2022: 2.1%FY 2023: -12.4%FY 2024: -20.2%FY 2025: -10.0%
FY 2016 FY 2025

Financial Health

Current Ratio 19.7×
FY 2016: 0.4×FY 2017: 3.1×FY 2018: 7.0×FY 2019: 11.5×FY 2020: 8.3×FY 2021: 3.0×FY 2022: 9.2×FY 2023: 15.0×FY 2024: 10.4×FY 2025: 19.7×
FY 2016 5y median 10.4× FY 2025
Quick Ratio 19.7×
FY 2016: 0.4×FY 2017: 3.1×FY 2018: 6.5×FY 2019: 11.5×FY 2020: 8.3×FY 2021: 3.0×FY 2022: 9.2×FY 2023: 15.0×FY 2024: 10.4×FY 2025: 19.7×
FY 2016 5y median 10.4× FY 2025
Debt / Equity 0.0×
FY 2016: -1.3×FY 2017: 0.4×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 0.5×FY 2021: 0.9×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: -1.6×FY 2017: 2.0×FY 2018: 0.9×FY 2019: 2.1×FY 2020: 1.0×FY 2021: 0.7×FY 2022: 0.1×FY 2023: 1.1×FY 2024: 0.7×FY 2025: 0.4×
FY 2016 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -2.5×FY 2018: -106×FY 2019: 0.0×FY 2020: -71.2×FY 2021: -27.0×FY 2022: -38.3×FY 2023: -86.8×FY 2024: -12881×FY 2025: 0.0×
FY 2016 5y median -38.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31